MMJ also has requested a meeting with FDA officials to discuss the development process for an investigational new drug (IND). A pre-IND meeting helps create a strategy for the drug development process by reviewing the clinical trial design, sharing ideas, and understanding the specific expectations and requirements for a future IND application. This step, in turn, may shorten the time necessary to bring the product to market.

“The filing of these applications with the FDA brings us one step closer to helping persons suffering from these debilitating diseases. As a company, we are committed to researching and developing cannabis based medicines which will improve the lives of people around the world,” said Duane Boise, CEO of MMJ, in a press release.

“The MMJ team expects many advantages by requesting a pre-IND meeting,” Boise added.

If approved, the company will conduct one of the first-ever clinical trials to assess the safety and effectiveness of using a natural botanical cannabis extract as a potential treatment for patients with Huntington’s disease and multiple sclerosis.

The clinical trials should generate new data regarding the benefits of using cannabis-based medicine on clinical outcomes, eventually leading to successful commercial drug development.

Preliminary studies have shown that cannabidiol — the non-psychoactive constituent of cannabis oil — displays neuro-protective qualities. As such, MMJ expects the clinical study will produce positive results and show benefits to treat these patients..

“Our unique scientific approach sets us apart from others in the industry, and we are working hard to create new and innovative pathways geared towards helping doctors treat and alleviating the suffering of patients,“ Boise said.

MMJ Bioscience, a subsidiary of MMJ International, is the first company to obtain a license from Health Canada to grow medical marijuana in Canada, and extract cannabinoids from the plant to use in FDA-approved clinical trials.

Huntington’s Disease News

Disclaimer:

Huntington's Disease News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

Pin It on Pinterest

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. We never use your cookies for creepy ad retargeting that follows you around the web. OkRead more